デフォルト表紙
市場調査レポート
商品コード
1427928

非オピオイド疼痛パッチの世界市場レポート 2024

Non-Opioid Pain Patch Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.45円
非オピオイド疼痛パッチの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

非オピオイド疼痛パッチの市場規模は、今後数年間で着実に成長すると予想されています。 2028年には4.8%の年間複合成長率(CAGR)で42億5,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、研究開発投資の増加、ヘルスケア支出の増加、支援的な規制環境、消費者の意識と教育の高まり、高齢者人口の拡大など、いくつかの重要な要因によるものと考えられます。予測期間中に予想される注目すべき動向には、ワイヤレスおよびスマートパッチ技術の採用、天然成分の統合、ウェアラブル技術とのコラボレーション、生分解性で環境に優しいパッチの開発、長期持続効果の達成への注目すべき焦点が含まれます。

非オピオイド疼痛パッチ市場で予想される成長は、慢性疼痛の有病率の増加によって促進されると予想されます。長期にわたる、しばしば重度の不快感を特徴とする慢性痛は、さまざまな医学的問題に関連する一般的な症状です。 非オピオイド疼痛パッチは、軽度から中程度の痛みを軽減するように設計されており、頭痛、筋肉痛、関節炎、腰痛などのさまざまな種類の痛みの治療に応用できます。特に、2021年5月に疾病管理予防センター(CDC)は、2019年から2021年の間に米国の成人における慢性疼痛の有病率は20.5%から21.8%の範囲であり、そのうち6.9%に影響の大きい慢性疼痛が影響していると報告しました。同じ期間に成人の7.8%に増加しました。 2021年には、推定5,160万人(20.9%)のアメリカ成人が慢性疼痛を経験していると報告し、1,710万人(6.9%)が衝撃の強い慢性疼痛を報告しました。この慢性疼痛の蔓延は、非オピオイド疼痛パッチ市場にとって重要な推進力となっています。

非オピオイド疼痛パッチ市場の成長は、研究開発(R&D)活動の増加によって促進されると予想されます。研究開発活動には、既存の製品や手順の改善、および新しいソリューションの開発を目的とした調査作業が含まれます。オピオイド依存と副作用に対する懸念が高まる中、非オピオイド疼痛管理オプションの開発、特にパッチ形式の開発が活発な調査分野となっています。たとえば、2023年 1月、国立科学工学統計センター(NCSES)は、米国の研究開発支出が2020年に7,170億米ドルに達し、2021年には7,919億米ドルになると推定されていると報告しました。この研究開発活動への多額の投資は、 非オピオイド疼痛パッチの進歩により、市場の成長が促進されました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の非オピオイド疼痛パッチ市場、パッチ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • リドカインパッチ
  • ジクロフェナクパッチ
  • カプサイシンパッチ
  • ケトプロフェンパッチ
  • その他のパッチ
  • 世界の非オピオイド疼痛パッチ市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • その他の流通チャネル
  • 世界の非オピオイド疼痛パッチ市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 筋骨格系疼痛
  • 神経因性疼痛

第7章 地域および国の分析

  • 世界の非オピオイド疼痛パッチ市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の非オピオイド疼痛パッチ市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 非オピオイド疼痛パッチ市場の競合情勢
  • 非オピオイド疼痛パッチ市場の企業プロファイル
    • Hisamitsu Pharmaceutical Co. Inc.
    • Pfizer Inc.
    • Novartis AG
    • Sanofi SA
    • GlaxoSmithKline plc

第31章 その他の大手および革新的な企業

  • Medtronic plc
  • Teva Pharmaceutical Industries Ltd.
  • Astellas Pharma Inc.
  • Aurobindo Pharma Limited
  • Purdue Pharma LP
  • Kyowa Kirin Co. Ltd.
  • Boehringer Ingelheim Pharmaceuticals Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Apotex Inc.
  • Endo Pharmaceuticals plc
  • Lupin Limited
  • Amneal Pharmaceuticals LLC
  • Daiichi Sankyo Company Limited
  • Glenmark Pharmaceuticals Private Limited
  • Mallinckrodt Pharmaceuticals LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13772

A non-opioid pain patch is a topical pain treatment that is both non-opioid and non-systemic, representing the sole available prescription-strength option in its category. This patch is designed to alleviate mild to moderate pain without the use of opioid substances.

The primary types of non-opioid pain patches include lidocaine patches, diclofenac patches, capsaicin patches, ketoprofen patches, and others. Lidocaine patches, for instance, are transdermal patches with analgesic properties. These patches are composed of a synthetic amide-type anesthetic, lidocaine, formulated in a 5 percent aqueous base solution. They serve the purpose of aiding in the treatment of itching and pain associated with certain skin disorders. Lidocaine patches are distributed through various channels, including hospital pharmacies, retail pharmacies, and other outlets. These patches find applications in treating various conditions, including musculoskeletal pain and neuropathic pain.

The non-opioid pain patch research report is one of a series of new reports from The Business Research Company that provides non-opioid pain patch market statistics, including the non-opioid pain patch industry's global market size, regional shares, competitors with non-opioid pain patch market share, detailed non-opioid pain patch market segments, market trends and opportunities, and any further data you may need to thrive in the non-opioid pain patch industry. This non-opioid pain patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. 

The non-opioid pain patch market size has grown strongly in recent years. It will grow from $3.34 billion in 2023 to $3.53 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth observed in the historical period can be ascribed to several factors, including a notable increase in chronic pain cases, a preference among patients for non-invasive treatment modalities, advancements in formulations and ingredients, a rise in sports-related injuries, and heightened concerns regarding opioid addiction.

The non-opioid pain patch market size is expected to see steady growth in the next few years. It will grow to $4.25 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The anticipated growth in the forecast period can be attributed to several key factors, including a rise in research and development investments, an increase in healthcare expenditure, a supportive regulatory environment, growing consumer awareness and education, and the expanding geriatric population. Noteworthy trends expected in the forecast period encompass the adoption of wireless and smart patch technologies, the integration of natural ingredients, collaboration with wearable technology, the development of biodegradable and eco-friendly patches, and a notable focus on achieving long-lasting effects.

The anticipated growth in the non-opioid pain patch market is expected to be driven by the increasing prevalence of chronic pain. Chronic pain, characterized by prolonged and often severe discomfort, is a prevalent condition associated with various medical issues. Non-opioid pain patches, designed to alleviate mild to moderate pain, find applications in treating diverse pain types such as headaches, muscle aches, arthritis, and backaches. Notably, in May 2021, the Centers for Disease Control and Prevention (CDC) reported that the prevalence of chronic pain among adults in the United States ranged from 20.5% to 21.8% between 2019 and 2021, with high-impact chronic pain affecting 6.9% to 7.8% of adults during the same period. In 2021, an estimated 51.6 million American adults (20.9%) reported experiencing chronic pain, while 17.1 million (6.9%) reported high-impact chronic pain. This escalating prevalence of chronic pain is a significant driver for the non-opioid pain patch market.

The growth of the non-opioid pain patch market is expected to be fueled by increased research and development (R&D) activities. R&D activities involve investigative work aimed at improving existing products or procedures and developing new solutions. With growing concerns about opioid dependence and side effects, the development of non-opioid pain management options, particularly in patch form, has become a dynamic area of research. For instance, in January 2023, the National Center for Science and Engineering Statistics (NCSES) reported that R&D spending in the United States reached $717.0 billion in 2020 and was estimated to be $791.9 billion in 2021. This substantial investment in R&D activities is contributing to the advancement of non-opioid pain patches, driving their market growth.

Product innovation is emerging as a prominent trend gaining traction in the non-opioid pain patch market, with major companies actively developing innovative solutions to enhance their market positions. An illustrative example is The Mentholatum Company Inc., a UK-based healthcare products manufacturer, which introduced the Deep Relief Actiflex Patch in June 2022. This drug-free pain patch features a cooling hydrogel containing water, offering fast cooling and soothing relief as the water evaporates on the skin. Specifically designed to treat aches and pains in muscles or joints, this innovative patch adds diversity to the non-opioid pain patch market.

Major companies in this market are focusing on the development of advanced products, including biocompatible surgical patches. These medical devices are utilized during surgical procedures to repair or reinforce injured tissues. In March 2021, Duke University, a renowned US-based private research university, introduced a non-opioid painkiller delivery system directly to wounds. This polymer patch delivers medication inhibiting the enzyme COX-2 (cyclooxygenase-2), known for causing pain and inflammation, providing sustained relief for days before naturally dissolving.

In October 2021, Pacira BioSciences, Inc., a US-based provider of non-opioid pain management and regenerative health solutions, made a strategic acquisition by purchasing Flexion Therapeutics, Inc., although the exact amount was undisclosed. This acquisition signifies a significant step forward in Pacira's strategy to establish a robust portfolio of innovative, non-opioid medicines, enhancing patient care along the neurological pain pathway. It also adds a complementary commercial asset in ZILRETTA, designed for the treatment of osteoarthritis knee pain.

Major companies operating in the non-opioid pain patch market report are Hisamitsu Pharmaceutical Co. Inc., Pfizer Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Medtronic PLC, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Aurobindo Pharma Limited, Purdue Pharma L.P., Kyowa Kirin Co. Ltd., Boehringer Ingelheim Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Endo Pharmaceuticals PLC, Lupin Limited, Amneal Pharmaceuticals LLC, Daiichi Sankyo Company Limited, Glenmark Pharmaceuticals Private Limited, Mallinckrodt Pharmaceuticals LLC, IBSA Institut Biochimque SA, Teikoku Seiyaku Co.Ltd., Acorda Therapeutics Inc., Sorrento Therapeutics Inc., Veridian Healthcare LLC, Clarion Brands LLC, Averitas Pharma Inc.

North America was the largest region in the non-opioid pain patch market in 2023. Asia-Pacific is expected to be the fastest-growing region in the non-opioid pain patch market report during the forecast period. The regions covered in the non-opioid pain patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the non-opioid pain patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-opioid pain patch market consists of sales of aspirin, ibuprofen, and acetaminophen patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-Opioid Pain Patch Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-opioid pain patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-opioid pain patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non-opioid pain patch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Patch: Lidocaine Patches; Diclofenac Patches; Capsaicin Patches; Ketoprofen Patches; Other Patches
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
  • 3) By Indication: Musculoskeletal Pain; Neuropathic Pain
  • Companies Mentioned: Hisamitsu Pharmaceutical Co. Inc.; Pfizer Inc.; Novartis AG; Sanofi S.A.; GlaxoSmithKline plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Non-Opioid Pain Patch Market Characteristics

3. Non-Opioid Pain Patch Market Trends And Strategies

4. Non-Opioid Pain Patch Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Non-Opioid Pain Patch Market Size and Growth

  • 5.1. Global Non-Opioid Pain Patch Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Non-Opioid Pain Patch Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Non-Opioid Pain Patch Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Non-Opioid Pain Patch Market Segmentation

  • 6.1. Global Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lidocaine Patches
  • Diclofenac Patches
  • Capsaicin Patches
  • Ketoprofen Patches
  • Other Patches
  • 6.2. Global Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels
  • 6.3. Global Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Musculoskeletal Pain
  • Neuropathic Pain

7. Non-Opioid Pain Patch Market Regional And Country Analysis

  • 7.1. Global Non-Opioid Pain Patch Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Non-Opioid Pain Patch Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Non-Opioid Pain Patch Market

  • 8.1. Asia-Pacific Non-Opioid Pain Patch Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Non-Opioid Pain Patch Market

  • 9.1. China Non-Opioid Pain Patch Market Overview
  • 9.2. China Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Non-Opioid Pain Patch Market

  • 10.1. India Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Non-Opioid Pain Patch Market

  • 11.1. Japan Non-Opioid Pain Patch Market Overview
  • 11.2. Japan Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Non-Opioid Pain Patch Market

  • 12.1. Australia Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Non-Opioid Pain Patch Market

  • 13.1. Indonesia Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Non-Opioid Pain Patch Market

  • 14.1. South Korea Non-Opioid Pain Patch Market Overview
  • 14.2. South Korea Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Non-Opioid Pain Patch Market

  • 15.1. Western Europe Non-Opioid Pain Patch Market Overview
  • 15.2. Western Europe Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Non-Opioid Pain Patch Market

  • 16.1. UK Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Non-Opioid Pain Patch Market

  • 17.1. Germany Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Non-Opioid Pain Patch Market

  • 18.1. France Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Non-Opioid Pain Patch Market

  • 19.1. Italy Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Non-Opioid Pain Patch Market

  • 20.1. Spain Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Non-Opioid Pain Patch Market

  • 21.1. Eastern Europe Non-Opioid Pain Patch Market Overview
  • 21.2. Eastern Europe Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Non-Opioid Pain Patch Market

  • 22.1. Russia Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Non-Opioid Pain Patch Market

  • 23.1. North America Non-Opioid Pain Patch Market Overview
  • 23.2. North America Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Non-Opioid Pain Patch Market

  • 24.1. USA Non-Opioid Pain Patch Market Overview
  • 24.2. USA Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Non-Opioid Pain Patch Market

  • 25.1. Canada Non-Opioid Pain Patch Market Overview
  • 25.2. Canada Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Non-Opioid Pain Patch Market

  • 26.1. South America Non-Opioid Pain Patch Market Overview
  • 26.2. South America Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Non-Opioid Pain Patch Market

  • 27.1. Brazil Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Non-Opioid Pain Patch Market

  • 28.1. Middle East Non-Opioid Pain Patch Market Overview
  • 28.2. Middle East Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Non-Opioid Pain Patch Market

  • 29.1. Africa Non-Opioid Pain Patch Market Overview
  • 29.2. Africa Non-Opioid Pain Patch Market, Segmentation By Patch, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Non-Opioid Pain Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Non-Opioid Pain Patch Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Non-Opioid Pain Patch Market Competitive Landscape And Company Profiles

  • 30.1. Non-Opioid Pain Patch Market Competitive Landscape
  • 30.2. Non-Opioid Pain Patch Market Company Profiles
    • 30.2.1. Hisamitsu Pharmaceutical Co. Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Pfizer Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Novartis AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi S.A.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GlaxoSmithKline plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Non-Opioid Pain Patch Market Other Major And Innovative Companies

  • 31.1. Medtronic plc
  • 31.2. Teva Pharmaceutical Industries Ltd.
  • 31.3. Astellas Pharma Inc.
  • 31.4. Aurobindo Pharma Limited
  • 31.5. Purdue Pharma L.P.
  • 31.6. Kyowa Kirin Co. Ltd.
  • 31.7. Boehringer Ingelheim Pharmaceuticals Inc.
  • 31.8. Dr. Reddy's Laboratories Ltd.
  • 31.9. Apotex Inc.
  • 31.10. Endo Pharmaceuticals plc
  • 31.11. Lupin Limited
  • 31.12. Amneal Pharmaceuticals LLC
  • 31.13. Daiichi Sankyo Company Limited
  • 31.14. Glenmark Pharmaceuticals Private Limited
  • 31.15. Mallinckrodt Pharmaceuticals LLC

32. Global Non-Opioid Pain Patch Market Competitive Benchmarking

33. Global Non-Opioid Pain Patch Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Non-Opioid Pain Patch Market

35. Non-Opioid Pain Patch Market Future Outlook and Potential Analysis

  • 35.1 Non-Opioid Pain Patch Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Non-Opioid Pain Patch Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Non-Opioid Pain Patch Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer